Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 05 2021
18 05 2021
Historique:
received:
01
11
2020
accepted:
28
04
2021
entrez:
19
5
2021
pubmed:
20
5
2021
medline:
29
5
2021
Statut:
epublish
Résumé
This was a population based cross-sectional study carried out to estimate and compare the seroprevalence, hidden prevalence and determine the demographic risk factors associated with SARS-CoV-2 infection among adults in the three largest cities of Odisha, India, and ascertain the association with the progression of the epidemic. The survey carried out in August 2020 in the three largest cities of the state of Odisha, India. Blood samples were collected from the residents using random sampling methods and tested for anti- SARS CoV-2 antibodies using an automated CLIA platform. A total of 4146 participants from the 3 cities of Bhubaneswar (BBS), Berhampur (BAM) and Rourkela (RKL) participated. The female to male participation ratio was 5.9:10 across the three cities. The gender weighted seroprevalence across the three cities was 20.78% (95% CI 19.56-22.05%). While females reported a higher seroprevalence (22.8%) as compared to males (18.8%), there was no significant difference in seroprevalence across age groups. A majority of the seropositive participants were asymptomatic (90.49%). The case to infection ratio on the date of serosurvey was 1:6.6 in BBS, 1:61 in BAM and 1:29.8 in RKL. The study found a high seroprevalence against COVID-19 in urban Odisha as well as high numbers of asymptomatic infections. The epidemic curves had a correlation with the seroprevalence.
Identifiants
pubmed: 34006960
doi: 10.1038/s41598-021-89877-y
pii: 10.1038/s41598-021-89877-y
pmc: PMC8131641
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
10551Investigateurs
Amiya Ranjan Mohanta
(AR)
Anjan Kumar Bishoyee
(AK)
Ashish Kumar Sadangi
(AK)
Ashok Kumar Mahakuda
(AK)
Biswakalyan Mishra
(B)
Dinabandhu Padhan
(D)
Gopinath Sethi
(G)
Hitesh Kumar Jain
(HK)
Janaki Biswal
(J)
Jeevan Kumar Mohanta
(JK)
Jitendriya Amrit Pritam
(JA)
Jwell Kiran Pradhan
(JK)
Kanhu Charan Sahoo
(KC)
Keshab Chandra Dalai
(KC)
Manas Kumar Bhoi
(MK)
Nirupama Sahoo
(N)
Nutan Dwibedi
(N)
Pradyuspita Sahoo
(P)
Sadruddin Khan
(S)
Sagarkanta Pradhan
(S)
Satyabrata Rout
(S)
Shakti Ranjan Barik
(SR)
Sithun Kumar Patro
(SK)
Smitanjali Samal
(S)
Soni Soni
(S)
Spandan Kumar Bhanjadeo
(SK)
Srikant Kumar Patra
(SK)
Subhralaxmi Dwivedy
(S)
Subrat Kumar Nayak
(SK)
Trilochan Bhoi
(T)
Références
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
J Coll Physicians Surg Pak. 2020 Jul;30(7):735-739
pubmed: 32811605
Euro Surveill. 2020 Jun;25(24):
pubmed: 32583766
Trop Med Int Health. 2016 Sep;21(9):1086-98
pubmed: 27300255
Cell Res. 2020 Sep;30(9):817-818
pubmed: 32686766
Int J Epidemiol. 2021 May 17;50(2):410-419
pubmed: 33615345
Indian J Med Res. 2020 May;151(5):419-423
pubmed: 32611913
J Clin Virol. 2020 Jul;128:104437
pubmed: 32434708
JAMA. 2020 Jul 14;324(2):195-197
pubmed: 32539107
Clin Chem Lab Med. 2020 Aug 26;58(12):2107-2111
pubmed: 32845861
Indian J Med Res. 2020 Jul & Aug;152(1 & 2):48-60
pubmed: 32952144
Front Immunol. 2020 Apr 24;11:879
pubmed: 32391022
J Clin Virol. 2020 Aug;129:104545
pubmed: 32659709
Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652
pubmed: 32584464
Am J Hum Biol. 2020 Sep;32(5):e23483
pubmed: 32776378
Expert Rev Mol Diagn. 2020 May;20(5):453-454
pubmed: 32297805